Isia Bursuker
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, CAR-T cell therapy research, T-cell and B-cell Immunology
Most-Cited Works
- → Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.(1984)248 cited
- → Discovery of Aminothiazole Inhibitors of Cyclin-Dependent Kinase 2: Synthesis, X-ray Crystallographic Analysis, and Biological Activities(2002)157 cited
- → Rakicidins, New Cytotoxic Lipopeptides from Micromonospora sp. Fermentation, Isolation and Characterization.(1995)94 cited
- → Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity.(1984)86 cited
- → Synthesis and Biological Evaluation of Analogues of Cryptolepine, an Alkaloid Isolated from the Suriname Rainforest(1999)72 cited
- On the origin of macrophage heterogeneity: a hypothesis.(1983)
- → DNA-Damaging Steroidal Alkaloids from Eclipta alba from the Suriname Rainforest(1998)68 cited
- → 1H-Pyrazolo[3,4-b]pyridine Inhibitors of Cyclin-Dependent Kinases(2003)63 cited
- → Fusaricide, a New Cytotoxic N-Hydroxypyridone from Fusarium sp.(1996)56 cited
- → A New Triterpene Saponin from Pittosporum viridiflorum from the Madagascar Rainforest(2001)56 cited